Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary.

MLA

Itamochi, Hiroaki, et al. “Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, vol. 24, no. 1, Jan. 2014, pp. 61–69. EBSCOhost, https://doi.org/10.1097/IGC.0000000000000014.

APA

Itamochi, H., Nishimura, M., Oumi, N., Kato, M., Oishi, T., Shimada, M., Sato, S., Naniwa, J., Sato, S., Kudoh, A., Kigawa, J., & Harada, T. (2014). Checkpoint kinase inhibitor AZD7762 overcomes cisplatin resistance in clear cell carcinoma of the ovary. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 24(1), 61–69. https://doi.org/10.1097/IGC.0000000000000014

Chicago

Itamochi, Hiroaki, Mayumi Nishimura, Nao Oumi, Misaki Kato, Tetsuro Oishi, Muneaki Shimada, Shinya Sato, et al. 2014. “Checkpoint Kinase Inhibitor AZD7762 Overcomes Cisplatin Resistance in Clear Cell Carcinoma of the Ovary.” International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society 24 (1): 61–69. doi:10.1097/IGC.0000000000000014.